Romano Brothers And Company Laboratory Corp Of America Holdings Transaction History

Romano Brothers And Company

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	SELL	$209.01 - $232.56 $167,208 - $186,048	-800 Reduced 5.35%	14,163 $3.09 Million
Q4 2023 Jan 29, 2024	BUY	$197.69 - $227.29 $2.96 Million - $3.4 Million	14,963 New	14,963 $3.4 Million
Q3 2023 Oct 17, 2023	BUY	$201.05 - $221.7 $3.04 Million - $3.35 Million	15,113 New	15,113 $3.04 Million
Q2 2023 Jul 12, 2023	SELL	$211.93 - $241.33 $31,789 - $36,199	-150 Reduced 0.97%	15,248 $3.68 Million
Q1 2023 Apr 13, 2023	SELL	$213.32 - $257.83 $178,122 - $215,288	-835 Reduced 5.14%	15,398 $3.53 Million
Q4 2022 Jan 17, 2023	BUY	$203.72 - $248.97 $20,372 - $24,897	100 Added 0.62%	16,233 $0
Q3 2022 Oct 18, 2022	BUY	$204.81 - $262.19 $3.3 Million - $4.23 Million	16,133 New	16,133 $3.31 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Romano Brothers And Company, based on Form 13F filings with the SEC.

Stay updated on Romano Brothers And Company with notifications on news.